Balancing the portfolio

In evaluating the planning dimensions that must be considered in order to balance a portfolio three major areas should be played off one against the other. These are  

None of these is independent of the other products may be brought into development along the timeline of vintages these may be inserted into one or more therapeutic areas and matched for their profit or market size. Major brands can be reinforced by life-cycle management initiatives including new formulations to extend the main franchise, different forms to suit a wider catchment of patients and the extension to new indications possibly by the use of different or novel formulations at the same time. 

---